Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

MESI

Explore full profile

An automatic ankle-brachial pressure index-measuring device (ABPI MD)

Ljubljana, SloveniaFounded 2010Biotech & Life Sciences
Valuation <$5M Last recorded · 2012
Revenue $10–50M Latest reported FY
Headcount 100–500 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for MESI and the history behind them.

About MESI

MESI, a company rooted in Slovenia, was established in 2010 by Jakob Šušterič and Tomo Krivc. The founders' journey began during their university years, where they identified a critical need for simplifying diagnostic measurements in healthcare. This realization led to the development of their first product, the MESI ABPI MD, which streamlines the Ankle-Brachial Index measurement, a key indicator for Peripheral Arterial Disease.

The company focuses on the development and manufacturing of medical devices aimed at simplifying and integrating diagnostic workflows for healthcare professionals. Its primary product is the MESI mTABLET, a modular system designed for primary care, specialist practices, and hospitals. This system integrates various diagnostic modules, such as a 12-lead ECG, spirometer, pulse oximeter, blood pressure monitor, and the aforementioned ABI measurement tool, into a single, portable device. This approach allows for immediate and comprehensive patient assessment, with all results being automatically stored in the patient's electronic record, the MESI mRECORDS.

MESI's business model revolves around the sale of its hardware—the mTABLET and its associated diagnostic modules—and a subscription-based service for its software platform, mRECORDS. This platform not only stores data but also enables clinicians to add clinical notes, share results for second opinions, and analyze the collected data. The company serves a global market, with a presence in over 50 countries, and operates through a network of distribution partners as well as direct sales via its subsidiaries in countries like Germany, France, the UK, and Italy.

Significant milestones for the company include receiving its first CE mark in 2012, which paved the way for its European expansion. By 2018, MESI had sold over 1,000 mTABLET systems, and by 2021, it had established a significant international footprint with multiple subsidiaries. The company has received numerous accolades for its product design and business growth, including Red Dot and German Design awards.

Source: Dealroom company data

At a glance

Founded
2010
Headquarters
Ljubljana, Slovenia
Sector
Biotech & Life Sciences

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • SHS Capital
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇸🇮 Slovenia · Ljubljana HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about MESI on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See MESI on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.